Overview
Dr. Sorenson has extensive research and policy expertise in value assessment in health care, comparative effectiveness research, drug and device regulation and payment, and health policy evaluation. She is interested in the design, implementation, and assessment of innovative, evidence-based strategies to enhance value-based health care, particularly with regards to new and existing health care treatments and services. In this work, she also examines the economic, methodological, political, cultural, organizational, professional, and legal levers that support or hinder the adoption of such approaches.
Dr. Sorenson’s work also focuses on education and training development in health policy and management. She is currently Faculty Director of Graduate Education Initiatives and the Margolis Scholars in Health Policy and Management Program at the Duke-Margolis Center for Health Policy.
Outside of academe, Dr. Sorenson has served in senior health care consulting and policy positions in both the private and public sectors. She has also worked in an advisory capacity for governmental organizations in several countries on development of national and regional health technology assessment systems.
Current Appointments & Affiliations
Recent Publications
Continuity of care (COC) and amyloid-β PET scan: the CARE-IDEAS study.
Journal Article Alzheimers Res Ther · January 7, 2023 BACKGROUND: High continuity of care (COC) is associated with better clinical outcomes among older adults. The impact of amyloid-β PET scan on COC among adults with mild cognitive impairment (MCI) or dementia of uncertain etiology is unknown. METHODS: We li ... Full text Link to item CiteImproving health equity for older people with serious illness through value based payment reform.
Journal Article J Am Geriatr Soc · July 2022 Full text Link to item CiteLow-Value Care De-implementation: Practices for Systemwide Reduction
Journal Article Nejm Catalyst Innovations in Care Delivery · April 20, 2022 Despite a growing body of evidence documenting the problem of low-value care, our understanding of how to effectively reduce or eliminate it remains limited. Through semistructured interviews with U.S. health care organizations with demonstrated experience ... Full text CiteRecent Grants
Implementing the Inflation Reduction Act: Proposal to Address Key Issues for Advancing Pharmaceutical Innovation, Access, Affordability, and Impact
ResearchFaculty Member · Awarded by National Pharmaceutical Council · 2024 - 2026Medicaid Best Price and the Medicaid Drug Rebate Program in the Context of Cell and Gene Therapies
ResearchFaculty Member · Awarded by Arnold Ventures · 2025 - 2026NC Medicaid Value-Based Payment Implementation
Public ServiceAdvisor · Awarded by NC Medicaid · 2022 - 2026View All Grants